| Dr Jay D Newcomer, OD | |
|
3636 N Lecanto Hwy, Beverly Hills, FL 34465-3513 | |
| (352) 746-0800 | |
| (352) 527-1358 |
| Full Name | Dr Jay D Newcomer |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 36 Years |
| Location | 3636 N Lecanto Hwy, Beverly Hills, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932247954 | NPI | - | NPPES |
| 410048608 | Other | FL | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC2301 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Newcomer Eyecare Ii, P.a. | 7214052836 | 2 |
News Archive
Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.
An assistant professor at Saint Louis University's College for Public Health and Social Justice has received a $100,000, two-year grant from the Robert Wood Johnson Foundation to determine which behaviors and policies are most likely to improve the health of African-American men.
Microsulis Medical Ltd (MML), the leading company in microwave technology for medical devices, has successfully launched the Acculis percutaneous microwave tissue ablation system, Accu2i pMTA, at the second European Conference on Interventional Oncology (ECIO) in Florence, Italy. A revolutionary new device for destroying tumours, the system is a 1.8mm diameter closed water-cooled needle, with performance matching the existing Acculis open surgery MTA system.
An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects on patients' outcomes or the brain.
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).
› Verified 6 days ago
| Provider Name | Newcomer Eyecare Ii, P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538367131 PECOS PAC ID: 7214052836 Enrollment ID: O20100920000078 |
News Archive
Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.
An assistant professor at Saint Louis University's College for Public Health and Social Justice has received a $100,000, two-year grant from the Robert Wood Johnson Foundation to determine which behaviors and policies are most likely to improve the health of African-American men.
Microsulis Medical Ltd (MML), the leading company in microwave technology for medical devices, has successfully launched the Acculis percutaneous microwave tissue ablation system, Accu2i pMTA, at the second European Conference on Interventional Oncology (ECIO) in Florence, Italy. A revolutionary new device for destroying tumours, the system is a 1.8mm diameter closed water-cooled needle, with performance matching the existing Acculis open surgery MTA system.
An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects on patients' outcomes or the brain.
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jay D Newcomer, OD 3636 N Lecanto Hwy, Beverly Hills, FL 34465-3513 Ph: (352) 746-0800 | Dr Jay D Newcomer, OD 3636 N Lecanto Hwy, Beverly Hills, FL 34465-3513 Ph: (352) 746-0800 |
News Archive
Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.
An assistant professor at Saint Louis University's College for Public Health and Social Justice has received a $100,000, two-year grant from the Robert Wood Johnson Foundation to determine which behaviors and policies are most likely to improve the health of African-American men.
Microsulis Medical Ltd (MML), the leading company in microwave technology for medical devices, has successfully launched the Acculis percutaneous microwave tissue ablation system, Accu2i pMTA, at the second European Conference on Interventional Oncology (ECIO) in Florence, Italy. A revolutionary new device for destroying tumours, the system is a 1.8mm diameter closed water-cooled needle, with performance matching the existing Acculis open surgery MTA system.
An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects on patients' outcomes or the brain.
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).
› Verified 6 days ago
Beverly Hills Eye Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 3636 N Lecanto Hwy, Beverly Hills, FL 34465 Phone: 352-746-0800 Fax: 352-527-1358 |